Handled with gentle pulse or beneath sure diurnal situations, photoreceptors can translocate into nucleus adopted by conformation change. Many vital elements of sunshine signaling pathways additionally majorly perform in nucleus. Therefore, it’s helpful to ascertain a mixed methodology to uncover and evaluate the nuclear proteomic panorama among the many mutants of sunshine signaling elements.
Right here we describe an optimized methodology to isolate nucleus with seedlings rising beneath gentle/darkish cycles for additional characterizing the nuclear proteome with label-free quantitation by liquid chromatography mass spectrometry (LC-MS).
Proteomics of Herpes Simplex Virus Sort 1 Nuclear Capsids
Herpes simplex virus replicates within the nucleus, the place new capsids are assembled. It produces procapsids devoid of nucleic acid however containing the preVP22a scaffold protein. These thermo-unstable particles then mature into A-, B- or C-nuclear icosahedral capsids, relying on their potential to shed the proteolytically processed scaffold and incorporation of the viral genome.
To review how these viral capsids differ, we carried out proteomics research of extremely enriched HSV-1 A-, B- and C-nuclear capsids, relying partially on a novel and highly effective circulate virometry method to purify C-capsids. We discovered that the viral particles contained the anticipated capsid elements and recognized a number of tegument proteins within the C-capsid fraction (pU<sub>L</sub>21, pU<sub>L</sub>36, pU<sub>L</sub>46, pU<sub>L</sub>48, pU<sub>L</sub>49, pU<sub>L</sub>50, pU<sub>L</sub>51 and pU<sub>S</sub>10).
Furthermore, quite a few ribosomal, hnRNPs and different host proteins, absent from the uninfected controls, have been detected on the capsids with a few of them seemingly particular to C-capsids (glycogen synthase, 4 completely different keratin-related proteins, fibronectin 1 and PCBP1). A subsequent proteomics evaluation was carried out to rule out the presence of protein complexes which will share related density because the viral capsids however don’t in any other case work together with them.
Utilizing pUL25 or VP5 mutant viruses incapable of assembling C-nuclear or all nuclear capsids, respectively, we confirmed the majority of our preliminary findings. Naturally, it is going to subsequent be vital to handle the purposeful relevance of those proteins.<b>IMPORTANCE</b> A lot is thought in regards to the biology of herpesviruses. This consists of their distinctive potential to traverse the 2 nuclear envelopes by sequential budding and fusion steps. For HSV-1, this means the pU<sub>L</sub>31/pU<sub>L</sub>34 and pU<sub>L</sub>17/pU<sub>L</sub>25 complexes which will favor C-capsid egress.
Nonetheless, this choice course of just isn’t clear, nor are all of the variations that distinguish A-, B- and C-capsids. The current examine probes what proteins compose these capsids, together with host proteins. This could open up new analysis avenues to make clear the biology of this most fascinating household of viruses. It additionally reiterates using circulate virometry as an revolutionary instrument to purify viral particles.
A Novel Proteomic Methodology Reveals NLS Tagging of T-DM1 Contravenes Classical Nuclear Transport in a Mannequin of HER2-Constructive Breast Most cancers
The following breakthrough for protein therapeutics is efficient intracellular supply and accumulation inside goal cells. Nuclear localization sign (NLS)-tagged therapeutics have been hindered by the shortage of environment friendly nuclear localization because of endosome entrapment.
Though improvement of methods for tagging therapeutics with applied sciences able to elevated membrane penetration has resulted in proportional elevated efficiency, nonspecific membrane penetration limits goal specificity and, therefore, widespread medical success. There’s a long-standing concept that nuclear localization of NLS-tagged brokers happens completely by way of classical nuclear transport.
Within the current examine, we modified the antibody-drug conjugate trastuzumab-emtansine (T-DM1) with a classical NLS linked to cholic acid (cell accumulator [Accum]) that permits modified antibodies to flee endosome entrapment and enhance nuclear localization effectivity with out abrogating receptor focusing on. In parallel, we developed a proteomics-based methodology to judge nuclear transport.
Accum-modified T-DM1 considerably enhanced cytotoxic efficacy within the human epidermal development issue receptor 2 (HER2)-positive SKBR3 breast most cancers system. We found that efficacy was depending on the nonclassical importin-7.
Our analysis reveals that when a number of classical NLS tagging happens, cationic cost build-up versus sequence dominates and turns into a substrate for importin-7. This examine leads to an efficient goal cell-specific NLS therapeutic and a normal method to information future NLS-based improvement initiatives.
Affinity proteomic dissection of the human nuclear cap-binding complicated interactome
A 5′,7-methylguanosine cap is a quintessential function of RNA polymerase II-transcribed RNAs, and a textbook side of co-transcriptional RNA processing. The cap is sure by the cap-binding complicated (CBC), canonically consisting of nuclear cap-binding proteins 1 and a couple of (NCBP1/2). Curiosity within the CBC has not too long ago renewed because of its participation in RNA-fate selections by way of interactions with RNA productive components in addition to with adapters of the degradative RNA exosome.
A novel cap-binding protein, NCBP3, was not too long ago proposed to type an alternate CBC along with NCBP1, and to work together with the canonical CBC together with the protein SRRT. The theme of post-transcriptional RNA destiny, and the way it pertains to co-transcriptional ribonucleoprotein meeting, is plentiful with difficult, ambiguous, and certain incomplete fashions.
Mouse C57 Embryo-E17 cDNA |
|||
MD-104-17-C57 | Zyagen | 30 reactions | EUR 280 |
Rat Musculoskeletal Embryonic Nuclear Protein 1 (MUSTN1) ELISA Kit |
|||
abx533781-96tests | Abbexa | 96 tests | EUR 687.5 |
Rat Mustn1 / Musculoskeletal embryonic nuclear protein 1 ELISA Kit |
|||
E6725r | EIAab | 96T | EUR 796 |
Recombinant Rat Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1430201-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1005 |
Recombinant Rat Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1430201-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 575 |
Recombinant Rat Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1430201-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 760 |
Recombinant Rat Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1430201-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 685 |
Recombinant Rat Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1430201-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 885 |
Mouse CD1 Embryo-E17 Total RNA |
|||
MR-104-17 | Zyagen | 0.1mg | EUR 160 |
Mouse C57 Embryo-E17 Total RNA |
|||
MR-104-17-C57 | Zyagen | 0.1mg | EUR 180 |
Mouse CD1 Embryo Sagittal Frozen Sections, E17 |
|||
MF-104-17 | Zyagen | 10 slides | EUR 257 |
Mouse C57 Embryo Sagittal Frozen Sections, E17 |
|||
MF-104-17-C57 | Zyagen | 10 slides | EUR 296 |
Musculoskeletal, Embryonic Nuclear Protein 1 Protein |
|||
20-abx263432 | Abbexa |
|
|
Musculoskeletal, Embryonic Nuclear Protein 1 Protein |
|||
abx263432-100mg | Abbexa | 100 mg | EUR 1600 |
Musculoskeletal, Embryonic Nuclear Protein 1 Protein |
|||
abx263432-25mg | Abbexa | 25 mg | EUR 225 |
Musculoskeletal, Embryonic Nuclear Protein 1 Protein |
|||
abx263432-50mg | Abbexa | 50 mg | EUR 325 |
Rat Embryo-E12 Total Protein |
|||
RT-104-12 | Zyagen | 0.5mg | EUR 153 |
Rat Embryo-E13 Total Protein |
|||
RT-104-13 | Zyagen | 0.5mg | EUR 153 |
Rat Embryo-E14 Total Protein |
|||
RT-104-14 | Zyagen | 0.5mg | EUR 153 |
Rat Embryo-E15 Total Protein |
|||
RT-104-15 | Zyagen | 0.5mg | EUR 153 |
Rat Embryo-E16 Total Protein |
|||
RT-104-16 | Zyagen | 0.5mg | EUR 153 |
Rat Embryo-E18 Total Protein |
|||
RT-104-18 | Zyagen | 1mg | EUR 153 |
Rat Embryo-E19 Total Protein |
|||
RT-104-19 | Zyagen | 1mg | EUR 153 |
Rat Embryo-E20 Total Protein |
|||
RT-104-20 | Zyagen | 1mg | EUR 153 |
Mustn1 (untagged ORF) - Rat musculoskeletal, embryonic nuclear protein 1 (Mustn1), (10 ug) |
|||
RN210106 | Origene Technologies GmbH | 10 µg | Ask for price |
Mouse CD1 Whole Embryo Sagittal Paraffin Sections, E17 |
|||
MP-104-17 | Zyagen | 10 slides | EUR 270 |
Mouse C57 Whole Embryo Sagittal Paraffin Sections, E17 |
|||
MP-104-17-C57 | Zyagen | 10 slides | EUR 296 |
Mustn1 (Myc-DDK-tagged ORF) - Rat musculoskeletal, embryonic nuclear protein 1 (Mustn1), (10 ug) |
|||
RR210106 | Origene Technologies GmbH | 10 µg | Ask for price |
Musculoskeletal, Embryonic Nuclear Protein 1 Human Recombinant |
|||
rAP-4206 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human Musculoskeletal, Embryonic Nuclear Protein 1 |
|||
MBS141096-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human Musculoskeletal, Embryonic Nuclear Protein 1 |
|||
MBS141096-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human Musculoskeletal, Embryonic Nuclear Protein 1 |
|||
MBS141096-01mg | MyBiosource | 0.1mg | EUR 1360 |
Recombinant Human Musculoskeletal, Embryonic Nuclear Protein 1 |
|||
MBS141096-5x01mg | MyBiosource | 5x0.1mg | EUR 5800 |
MUSTN1 Musculoskeletal, Embryonic Nuclear Protein 1 Human Recombinant Protein |
|||
PROTQ8IVN3 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: MUSTN1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 105 amino acids (1-82 a.a) and having a molecular mass of 11.3kDa. MUSTN1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
Human Musculoskeletal embryonic nuclear protein 1(MUSTN1) Elisa Kit |
|||
EK713075 | AFG Bioscience LLC | 96 Wells | EUR 0.32 |
Human Musculoskeletal embryonic nuclear protein 1,MUSTN1 ELISA KIT |
|||
E5706Hu-1096T | Jiaxing Korain Biotech Ltd (BT Labs) | 10*96T | EUR 4122 |
Human Musculoskeletal embryonic nuclear protein 1,MUSTN1 ELISA KIT |
|||
E5706Hu-48wells | Jiaxing Korain Biotech Ltd (BT Labs) | 48 wells | EUR 300 |
Human Musculoskeletal embryonic nuclear protein 1,MUSTN1 ELISA KIT |
|||
E5706Hu-596T | Jiaxing Korain Biotech Ltd (BT Labs) | 5*96T | EUR 2061 |
Human Musculoskeletal embryonic nuclear protein 1,MUSTN1 ELISA KIT |
|||
E5706Hu-96wells | Jiaxing Korain Biotech Ltd (BT Labs) | 96 wells | EUR 458 |
Human Musculoskeletal Embryonic Nuclear Protein 1 (MUSTN1) ELISA Kit |
|||
abx533779-96tests | Abbexa | 96 tests | EUR 687.5 |
Mouse Musculoskeletal Embryonic Nuclear Protein 1 (MUSTN1) ELISA Kit |
|||
abx533780-96tests | Abbexa | 96 tests | EUR 687.5 |
Human MUSTN1 / Musculoskeletal embryonic nuclear protein 1 ELISA Kit |
|||
E6725h | EIAab | 96T | EUR 736 |
Mouse Mustn1 / Musculoskeletal embryonic nuclear protein 1 ELISA Kit |
|||
E6725m | EIAab | 96T | EUR 776 |
Human Musculoskeletal embryonic nuclear protein 1, MUSTN1 ELISA Kit |
|||
MBS1606600-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3460 |
Human Musculoskeletal embryonic nuclear protein 1, MUSTN1 ELISA Kit |
|||
MBS1606600-48StripWells | MyBiosource | 48-Strip-Wells | EUR 285 |
Human Musculoskeletal embryonic nuclear protein 1, MUSTN1 ELISA Kit |
|||
MBS1606600-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1750 |
Human Musculoskeletal embryonic nuclear protein 1, MUSTN1 ELISA Kit |
|||
MBS1606600-96StripWells | MyBiosource | 96-Strip-Wells | EUR 425 |
Bovine MUSTN1 / Musculoskeletal embryonic nuclear protein 1 ELISA Kit |
|||
E6725b | EIAab | 96T | EUR 900 |
Chicken MUSTN1 / Musculoskeletal embryonic nuclear protein 1 ELISA Kit |
|||
E6725c | EIAab | 96T | EUR 900 |
Recombinant Bovine Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1309431-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1005 |
Recombinant Bovine Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1309431-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 575 |
Recombinant Bovine Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1309431-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 760 |
Recombinant Bovine Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1309431-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 685 |
Recombinant Bovine Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1309431-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 885 |
Recombinant Human Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1459395-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1005 |
Recombinant Human Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1459395-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 575 |
Recombinant Human Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1459395-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 760 |
Recombinant Human Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1459395-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 685 |
Recombinant Human Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1459395-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 885 |
Recombinant Mouse Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1415941-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1005 |
Recombinant Mouse Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1415941-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 575 |
Recombinant Mouse Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1415941-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 760 |
Recombinant Mouse Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1415941-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 685 |
Recombinant Mouse Musculoskeletal embryonic nuclear protein 1 (Mustn1) |
|||
MBS1415941-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 885 |
Lenti ORF clone of Mustn1 (mGFP-tagged ORF) - Rat musculoskeletal, embryonic nuclear protein 1 (Mustn1), (10 ug) |
|||
RR210106L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Musculoskeletal embryonic nuclear Protein 1, MUSTN1 GENLISA ELISA |
|||
KBH5706 | Krishgen | 1 x 96 wells | EUR 286 |
Recombinant Chicken Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1405835-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1000 |
Recombinant Chicken Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1405835-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 570 |
Recombinant Chicken Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1405835-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 755 |
Recombinant Chicken Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1405835-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 680 |
Recombinant Chicken Musculoskeletal embryonic nuclear protein 1 (MUSTN1) |
|||
MBS1405835-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 880 |
MUSTN1 (untagged)-Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1) |
|||
SC308241 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Mustn1 (Myc-DDK-tagged ORF) - Rat musculoskeletal, embryonic nuclear protein 1 (Mustn1), (10 ug) |
|||
RR210106L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Rat Embryo Total Protein Panel, Set of 5 Embryos |
|||
RT-104-005 | Zyagen | 5x0.1mg | EUR 567 |
Rat Embryo Total Protein Panel, Set of 9 Embryos |
|||
RT-104-009 | Zyagen | 9x0.1mg | EUR 858 |
Mustn1 (untagged) - Mouse musculoskeletal, embryonic nuclear protein 1 (Mustn1), (10ug) |
|||
MC210293 | Origene Technologies GmbH | 10 µg | Ask for price |
MUSTN1 (GFP-tagged) - Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1) |
|||
RG214142 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Mustn1 (GFP-tagged ORF) - Rat musculoskeletal, embryonic nuclear protein 1 (Mustn1), 200ul, >10^7 TU/mL |
|||
RR210106L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Mustn1 (Myc-DDK-tagged) - Mouse musculoskeletal, embryonic nuclear protein 1 (Mustn1) |
|||
MR224559 | Origene Technologies GmbH | 10 µg | Ask for price |
Mustn1 (GFP-tagged) - Mouse musculoskeletal embryonic nuclear protein 1 (Mustn1), (10ug) |
|||
MG224559 | Origene Technologies GmbH | 10 µg | Ask for price |
MUSTN1 (Myc-DDK-tagged)-Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1) |
|||
RC214142 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Mustn1 (Myc-DDK-tagged ORF) - Rat musculoskeletal, embryonic nuclear protein 1 (Mustn1), 200ul, >10^7 TU/mL |
|||
RR210106L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), mGFP tagged |
|||
RC214142L2 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), mGFP tagged |
|||
RC214142L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Rat Embryo-E12 cDNA |
|||
RD-104-12 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E13 cDNA |
|||
RD-104-13 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E14 cDNA |
|||
RD-104-14 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E15 cDNA |
|||
RD-104-15 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E16 cDNA |
|||
RD-104-16 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E18 cDNA |
|||
RD-104-18 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E19 cDNA |
|||
RD-104-19 | Zyagen | 30 reactions | EUR 243 |
Rat Embryo-E20 cDNA |
|||
RD-104-20 | Zyagen | 30 reactions | EUR 243 |
Lenti ORF clone of Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), Myc-DDK-tagged |
|||
RC214142L1 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), Myc-DDK-tagged |
|||
RC214142L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Mustn1 (mGFP-tagged) - Mouse musculoskeletal, embryonic nuclear protein 1 (Mustn1) |
|||
MR224559L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Mouse CD1 Embryo-E11Total Protein |
|||
MT-104-11 | Zyagen | 0.5mg | EUR 153 |
Mouse C57 Embryo-E11Total Protein |
|||
MT-104-11-C57 | Zyagen | 0.5mg | EUR 180 |
Lenti ORF clone of Mustn1 (Myc-DDK-tagged) - Mouse musculoskeletal, embryonic nuclear protein 1 (Mustn1) |
|||
MR224559L3 | Origene Technologies GmbH | 10 µg | Ask for price |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) |
|||
MBS648098-02mL | MyBiosource | 0.2mL | EUR 695 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) |
|||
MBS648098-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (AP) |
|||
MBS6330395-02mL | MyBiosource | 0.2mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (AP) |
|||
MBS6330395-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (APC) |
|||
MBS6330396-02mL | MyBiosource | 0.2mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (APC) |
|||
MBS6330396-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (Biotin) |
|||
MBS6330397-02mL | MyBiosource | 0.2mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (Biotin) |
|||
MBS6330397-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (FITC) |
|||
MBS6330398-02mL | MyBiosource | 0.2mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (FITC) |
|||
MBS6330398-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (PE) |
|||
MBS6330405-02mL | MyBiosource | 0.2mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (PE) |
|||
MBS6330405-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Mouse CD1 Embryo-E12 Total Protein |
|||
MT-104-12 | Zyagen | 0.5mg | EUR 153 |
Mouse C57 Embryo-E12 Total Protein |
|||
MT-104-12-C57 | Zyagen | 0.5mg | EUR 180 |
Mouse CD1 Embryo-E13 Total Protein |
|||
MT-104-13 | Zyagen | 0.5mg | EUR 153 |
Mouse C57 Embryo-E13 Total Protein |
|||
MT-104-13-C57 | Zyagen | 0.5mg | EUR 180 |
Mouse CD1 Embryo-E14 Total Protein |
|||
MT-104-14 | Zyagen | 0.5mg | EUR 153 |
Mouse C57 Embryo-E14 Total Protein |
|||
MT-104-14-C57 | Zyagen | 0.5mg | EUR 180 |
Mouse CD1 Embryo-E15 Total Protein |
|||
MT-104-15 | Zyagen | 0.5mg | EUR 153 |
Mouse C57 Embryo-E15 Total Protein |
|||
MT-104-15-C57 | Zyagen | 0.5mg | EUR 180 |
Mouse CD1 Embryo-E16 Total Protein |
|||
MT-104-16 | Zyagen | 1mg | EUR 153 |
Mouse C57 Embryo-E16 Total Protein |
|||
MT-104-16-C57 | Zyagen | 1mg | EUR 180 |
Mouse CD1 Embryo-E18 Total Protein |
|||
MT-104-18 | Zyagen | 1mg | EUR 153 |
Mouse C57 Embryo-E18 Total Protein |
|||
MT-104-18-C57 | Zyagen | 1mg | EUR 180 |
Rat Embryo-E12 Total RNA |
|||
RR-104-12 | Zyagen | 0.025mg | EUR 160 |
Rat Embryo-E13 Total RNA |
|||
RR-104-13 | Zyagen | 0.025mg | EUR 160 |
Rat Embryo-E14 Total RNA |
|||
RR-104-14 | Zyagen | 0.05mg | EUR 160 |
Rat Embryo-E15 Total RNA |
|||
RR-104-15 | Zyagen | 0.05mg | EUR 160 |
Rat Embryo-E16 Total RNA |
|||
RR-104-16 | Zyagen | 0.1mg | EUR 160 |
Rat Embryo-E18 Total RNA |
|||
RR-104-18 | Zyagen | 0.2mg | EUR 160 |
Rat Embryo-E19 Total RNA |
|||
RR-104-19 | Zyagen | 0.2mg | EUR 160 |
Rat Embryo-E20 Total RNA |
|||
RR-104-20 | Zyagen | 0.2mg | EUR 160 |
Rat Embryo Frozen Sagittal Sections, E12 |
|||
RF-104-12 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Frozen Sagittal Sections, E13 |
|||
RF-104-13 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Frozen Sagittal Sections, E14 |
|||
RF-104-14 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Frozen Sagittal Sections, E15 |
|||
RF-104-15 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Frozen Sagittal Sections, E16 |
|||
RF-104-16 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Frozen Sagittal Sections, E18 |
|||
RF-104-18 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Frozen Sagittal Sections, E19 |
|||
RF-104-19 | Zyagen | 10 slides | EUR 270 |
Lenti ORF particles, Mustn1 (GFP-tagged) - Mouse musculoskeletal, embryonic nuclear protein 1 (Mustn1), 200ul, >10^7 TU/mL |
|||
MR224559L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MUSTN1 (mGFP-tagged) - Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), 200ul, >10^7 TU/mL |
|||
RC214142L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MUSTN1 (mGFP-tagged) - Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), 200ul, >10^7 TU/mL |
|||
RC214142L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Rat Embryo Paraffin Sagittal Sections, E12 |
|||
RP-104-12 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Paraffin Sagittal Sections, E13 |
|||
RP-104-13 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Paraffin Sagittal Sections, E14 |
|||
RP-104-14 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Paraffin Sagittal Sections, E15 |
|||
RP-104-15 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Paraffin Sagittal Sections, E16 |
|||
RP-104-16 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Paraffin Sagittal Sections, E18 |
|||
RP-104-18 | Zyagen | 10 slides | EUR 270 |
Rat Embryo Paraffin Sagittal Sections, E19 |
|||
RP-104-19 | Zyagen | 10 slides | EUR 270 |
Lenti ORF particles, MUSTN1 (Myc-DDK tagged) - Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), 200ul, >10^7 TU/mL |
|||
RC214142L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MUSTN1 (Myc-DDK tagged) - Human musculoskeletal, embryonic nuclear protein 1 (MUSTN1), 200ul, >10^7 TU/mL |
|||
RC214142L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Rabbit Embryo, whole Total Protein |
|||
TT-104 | Zyagen | 0.5mg | EUR 153 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 405) |
|||
MBS6330400-01mL | MyBiosource | 0.1mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 405) |
|||
MBS6330400-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 490) |
|||
MBS6330401-01mL | MyBiosource | 0.1mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 490) |
|||
MBS6330401-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 550) |
|||
MBS6330402-01mL | MyBiosource | 0.1mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 550) |
|||
MBS6330402-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 650) |
|||
MBS6330403-01mL | MyBiosource | 0.1mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 650) |
|||
MBS6330403-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 750) |
|||
MBS6330404-01mL | MyBiosource | 0.1mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (MaxLight 750) |
|||
MBS6330404-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (Azide free) (HRP) |
|||
MBS6330399-02mL | MyBiosource | 0.2mL | EUR 980 |
PABPN1L, ID (PABPN1L, EPABP2, PABPNL1, Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein type II, Poly(A)-binding protein nuclear-like 1) (Azide free) (HRP) |
|||
MBS6330399-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Lenti ORF particles, Mustn1 (Myc-DDK-tagged) - Mouse musculoskeletal, embryonic nuclear protein 1 (Mustn1), 200ul, >10^7 TU/mL |
|||
MR224559L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Rat Whole Embryo Western Blot |
|||
RW-104 | Zyagen | 1 Blot | EUR 668 |
Rat Embryo cDNA Panel, Set of 9 Embryos |
|||
RD-104-009 | Zyagen | 9x10 reactions | EUR 1158 |
Mouse CD1 Embryo Total Protein Panel, Set of 5 Embryos |
|||
MT-104-005 | Zyagen | 5x0.1mg | EUR 567 |
In an effort to make clear the compositions of NCBP1-, 2- and 3-related macromolecular assemblies, now we have utilized an affinity capture-based interactome display the place the experimental design and information processing have been modified to quantitatively establish interactome variations between targets beneath a variety of experimental situations. This examine generated a complete view of NCBP-protein interactions within the ribonucleoprotein context and demonstrates the potential of our method to profit the interpretation of complicated organic pathways.